Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF STOCKHOLDERS' EQUITY

STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) In Thousands, except Share data, unless otherwise specified	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Other Comprehensive Income [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2011	$ 71	$ 897,479	$ 6	$ (661,407)	$ 236,149us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2011	71,379,052
Increase (Decrease) in Stockholders' Equity
Net loss				(98,840)	(98,840)
Net change in unrealized gain on short-term investments			76		76
Issuance of common stock at $9.50 per share for cash, net of issuance costs	15	135,714			135,729
Issuance of common stock, net of issuance costs (in shares)	15,237,750
Issuance of common stock upon exercise of options and participation in Purchase Plan	1	3,364			3,365
Issuance of common stock upon exercise of options and participation in Purchase Plan (in shares)	523,830
Stock compensation expense		12,617			12,617rigl_StockCompensationExpenses
Balance at Dec. 31, 2012	87	1,049,174	82	(760,247)	289,096us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2012	87,140,632
Increase (Decrease) in Stockholders' Equity
Net loss				(89,027)	(89,027)
Net change in unrealized gain on short-term investments			(35)		(35)
Issuance of common stock upon exercise of options and participation in Purchase Plan	1	1,050			1,051
Issuance of common stock upon exercise of options and participation in Purchase Plan (in shares)	383,717
Stock compensation expense		7,166			7,166rigl_StockCompensationExpenses
Balance at Dec. 31, 2013	88	1,057,390	47	(849,274)	208,251us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2013	87,524,349
Increase (Decrease) in Stockholders' Equity
Net loss				(90,908)	(90,908)
Net change in unrealized gain on short-term investments			(54)		(54)
Issuance of common stock upon exercise of options and participation in Purchase Plan		1,170			1,170
Issuance of common stock upon exercise of options and participation in Purchase Plan (in shares)	517,096
Stock compensation expense		9,787			9,787rigl_StockCompensationExpenses
Balance at Dec. 31, 2014	$ 88	$ 1,068,347	$ (7)	$ (940,182)	$ 128,246us-gaap_StockholdersEquity
Balance (in shares) at Dec. 31, 2014	88,041,445